Bioiberica to present in Malaysia two seminars on novel biomolecules for the management of highly prevalent diseases in pet animals
Roger Sabata, Bioiberica’s Medical Marketing Manager, will present two talks at the UPM and Johor Baru veterinary medicine faculties
On 17-18 April, 2018, Bioiberica will attend the UPM and Johor Bahru veterinary medicine faculties. Together with Vetcare, their distributor in Malaysia, they will present a seminar on novel biomolecules for the management of highly prevalent diseases in small animals. The talk will consist of the following sections:
- Chronic gastrointestinal issues
- Feline idiopatic cistitis
- Immune system and leishmaniasis
- Atopic dermatitis
The head of Medical Marketing at Bioiberica, Roger Sabata, will discuss the various therapeutic tools available for the treatment of these diseases, which are highly prevalent among pet animals; for them, Bioiberica puts forward therapeutic solutions based on biomolecules with top quality and high safety profiles.
Bioiberica is a company specializing in the extraction of animal origin biomolecules of maximum quality and traceability. These biomolecules are used in human and veterinary health, animal nutrition and plant physiology. Bioiberica’s Companion Animal Division has created innovating ranges of products for pet animal healthcare. Products such as Atopivet, Entero-Chronic, Calmurofel and Impromune are therapeutic options based on biomolecules which are efficient as well as safe.
Related News
This year's winning product was DermalEase/Atopivet drops and mousse - a topical skin care solution.
Pet food is constantly evolving, with new and innovative products being introduced to promote a healthier and more conscious nutrition for pets.
- This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
- The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®